Literature DB >> 11422193

Membrane cofactor protein (MCP; CD46) expression in transgenic mice.

C Kemper1, M Leung, C B Stephensen, C A Pinkert, M K Liszewski, R Cattaneo, J P Atkinson.   

Abstract

Human membrane cofactor protein (MCP; CD46) is a widely distributed complement regulator. In the mouse, expression of MCP is largely restricted to the testis while a related, widely expressed protein (Crry) appears to perform MCP's (CD46) regulatory activity. We have developed two mouse strains transgenic for human MCP (CD46) utilizing an approximately 400 kb YAC clone carrying the complete gene. A third mouse strain was generated using an overlapping YAC clone isolated from a second library. The expression of human MCP (CD46) in these mouse strains was characterized by immunohistochemistry, FACS, Western blotting and RT-PCR. No differences were detected in the isoform pattern or distribution among the three strains, although the expression level varied according to how many copies of the gene were integrated. The expression profile closely mimicked that observed in humans, including the same pattern of isoform expression as the donor. In addition, tissue-specific isoform expression in the kidney, salivary gland and brain paralleled that observed in man. The transgenic mice expressed low levels of MCP (CD46) on their E, in contrast to humans but in line with most other primates. These mice should be a useful tool to analyse tissue-specific expression, to establish animal models of infections and to characterize the role of MCP (CD46) in reproduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422193      PMCID: PMC1906059          DOI: 10.1046/j.1365-2249.2001.01458.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

1.  A critical role for murine complement regulator crry in fetomaternal tolerance.

Authors:  C Xu; D Mao; V M Holers; B Palanca; A M Cheng; H Molina
Journal:  Science       Date:  2000-01-21       Impact factor: 47.728

2.  Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice.

Authors:  B Mrkic; B Odermatt; M A Klein; M A Billeter; J Pavlovic; R Cattaneo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans.

Authors:  S Lozahic; D Christiansen; S Manié; D Gerlier; M Billard; C Boucheix; E Rubinstein
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

4.  CD46 is a cellular receptor for human herpesvirus 6.

Authors:  F Santoro; P E Kennedy; G Locatelli; M S Malnati; E A Berger; P Lusso
Journal:  Cell       Date:  1999-12-23       Impact factor: 41.582

Review 5.  Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions.

Authors:  T Seya; A Hirano; M Matsumoto; M Nomura; S Ueda
Journal:  Int J Biochem Cell Biol       Date:  1999-11       Impact factor: 5.085

6.  Characterization of CR1- and membrane cofactor protein-like proteins of two primates.

Authors:  M W Nickells; J P Atkinson
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

7.  A human cell-surface antigen defined by a monoclonal antibody and controlled by a gene on human chromosome 1.

Authors:  P W Andrews; B B Knowles; M Parkar; B Pym; K Stanley; P N Goodfellow
Journal:  Ann Hum Genet       Date:  1985-01       Impact factor: 1.670

8.  Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.

Authors:  J L Cole; G A Housley; T R Dykman; R P MacDermott; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp45-70).

Authors:  L Ballard; T Seya; J Teckman; D M Lublin; J P Atkinson
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

10.  Functional properties of membrane cofactor protein of complement.

Authors:  T Seya; J P Atkinson
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

View more
  47 in total

1.  Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors.

Authors:  Dmitry M Shayakhmetov; Zong-Yi Li; Shaoheng Ni; André Lieber
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 2.  T-cell stimulation and regulation: with complements from CD46.

Authors:  Claudia Kemper; James W Verbsky; Jeffrey D Price; John P Atkinson
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Roles of macrophages in measles virus infection of genetically modified mice.

Authors:  B Roscic-Mrkic; R A Schwendener; B Odermatt; A Zuniga; J Pavlovic; M A Billeter; R Cattaneo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice.

Authors:  Chang Li; Kevin A Goncalves; Tamás Raskó; Amit Pande; Sucheol Gil; Zhinan Liu; Zsuzsanna Izsvák; Thalia Papayannopoulou; John C Davis; Hans-Peter Kiem; André Lieber
Journal:  Blood Adv       Date:  2021-03-09

5.  Development and assessment of human adenovirus type 11 as a gene transfer vector.

Authors:  Daniel Stone; Shaoheng Ni; Zong-Yi Li; Anuj Gaggar; Nelson DiPaolo; Qinghua Feng; Volker Sandig; André Lieber
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice.

Authors:  Chang Li; Aphrodite Georgakopoulou; Arpit Mishra; Sucheol Gil; R David Hawkins; Evangelia Yannaki; André Lieber
Journal:  Blood Adv       Date:  2021-02-23

7.  An immune competent mouse model for the characterization of recombinant measles vaccines.

Authors:  René R Marty; Marlyse C Knuchel; Teldja Neige Azzouz Morin; Hussein Y Naim
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

8.  Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.

Authors:  Pavlos Msaouel; Ianko D Iankov; Cory Allen; Ileana Aderca; Mark J Federspiel; Donald J Tindall; John C Morris; Michael Koutsilieris; Stephen J Russell; Evanthia Galanis
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

Review 9.  Oncolytic measles virus strains as novel anticancer agents.

Authors:  Pavlos Msaouel; Mateusz Opyrchal; Evidio Domingo Musibay; Evanthia Galanis
Journal:  Expert Opin Biol Ther       Date:  2013-01-06       Impact factor: 4.388

10.  Functional dissection of Streptococcus pyogenes M5 protein: the hypervariable region is essential for virulence.

Authors:  Johan Waldemarsson; Margaretha Stålhammar-Carlemalm; Charlotta Sandin; Francis J Castellino; Gunnar Lindahl
Journal:  PLoS One       Date:  2009-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.